Kanamori Y - Search Results

1

Clinical responses and platinum concentrations in tumors after intra-arterial and intravenous administration of cisplatin in the same patients with cervical cancer.

Kanamori Y, Kigawa J, Minagawa Y, Irie T, Itamochi H, Cheng X, Okada M, Terakawa N. Kanamori Y, et al. Gynecol Obstet Invest. 1997;44(1):57-60. doi: 10.1159/000291411. Gynecol Obstet Invest. 1997. PMID: 9251956

2

Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.

Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N. Shimada M, et al. Among authors: kanamori y. Gynecol Oncol. 2004 Jun;93(3):628-31. doi: 10.1016/j.ygyno.2004.03.011. Gynecol Oncol. 2004. PMID: 15196855 Clinical Trial.

3

Feasibility study comparing docetaxel-cisplatin versus docetaxel-carboplatin as first-line chemotherapy for ovarian cancer.

Minagawa Y, Kigawa J, Kanamori Y, Itamochi H, Terakawa N, Okada M, Kitada F. Minagawa Y, et al. Among authors: kanamori y. Gynecol Oncol. 2006 Jun;101(3):495-8. doi: 10.1016/j.ygyno.2005.11.020. Epub 2006 Jan 10. Gynecol Oncol. 2006. PMID: 16375950 Clinical Trial.

4

Response rate and cell-cycle changes due to intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent uterine cervical cancer.

Kigawa J, Kanamori Y, Ishihara H, Minagawa Y, Iwamoto K, Terakawa N. Kigawa J, et al. Among authors: kanamori y. Am J Clin Oncol. 1992 Dec;15(6):474-9. Am J Clin Oncol. 1992. PMID: 1280402

5

The influence of intra-arterial infusion of cisplatinum and bleomycin on the cell cycle in uterine cervical carcinoma.

Kigawa J, Kanamori Y, Morishita K, Ishihara H, Minagawa Y, Maeda K. Kigawa J, et al. Among authors: kanamori y. Nihon Gan Chiryo Gakkai Shi. 1990 Nov 20;25(11):2665-9. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 1703556

6

Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.

Kigawa J, Minagawa Y, Itamochi H, Kanamori Y, Ishihara H, Terakawa N. Kigawa J, et al. Among authors: kanamori y. Obstet Gynecol. 1995 Aug;86(2):265-8. doi: 10.1016/0029-7844(95)00117-a. Obstet Gynecol. 1995. PMID: 7617358

7

Tumor cell kinetics in elderly patients with cervical cancer.

Minagawa Y, Kigawa J, Kanamori Y, Itamochi H, Terakawa N. Minagawa Y, et al. Among authors: kanamori y. Obstet Gynecol. 1993 Apr;81(4):610-4. Obstet Gynecol. 1993. PMID: 7681554

8

Involvement of the local immune response in a case of advanced cervical cancer in a patient with systemic lupus erythematosus.

Kigawa J, Kanamori Y, Takeuchi Y, Minagawa Y, Terakawa N. Kigawa J, et al. Among authors: kanamori y. Gynecol Obstet Invest. 1993;36(1):62-4. doi: 10.1159/000292597. Gynecol Obstet Invest. 1993. PMID: 8349182

9

The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer.

Kigawa J, Minagawa Y, Ishihara H, Itamochi H, Kanamori Y, Terakawa N. Kigawa J, et al. Among authors: kanamori y. Am J Clin Oncol. 1996 Jun;19(3):255-9. doi: 10.1097/00000421-199606000-00009. Am J Clin Oncol. 1996. PMID: 8638536 Clinical Trial.

10

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.

Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N. Kigawa J, et al. Among authors: kanamori y. Cancer. 1998 Feb 15;82(4):697-702. doi: 10.1002/(sici)1097-0142(19980215)82:4<697::aid-cncr12>3.0.co;2-t. Cancer. 1998. PMID: 9477102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters